CD63 and breast carcinoma: After optimization of the exosome isolation from MDA-231 breast cancer cells in 2D cultures we verified the successful exosome harvesting through TEM (Fig. 1a) and immunoblot protein analysis of well-established exosome markers CD63 and CD81 [13, 22] (Fig. 1b).